Pages that link to "Q48430921"
The following pages link to Collagen cross-linking but not collagen amount associates with elevated filling pressures in hypertensive patients with stage C heart failure: potential role of lysyl oxidase (Q48430921):
Displaying 50 items.
- The role of titin and extracellular matrix remodelling in heart failure with preserved ejection fraction (Q26765101) (← links)
- Myocardial fibrosis: biomedical research from bench to bedside. (Q30362840) (← links)
- Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female mice (Q33644666) (← links)
- Mimicking Cardiac Fibrosis in a Dish: Fibroblast Density Rather than Collagen Density Weakens Cardiomyocyte Function (Q33705089) (← links)
- Matrix Mechanosensing: From Scaling Concepts in 'Omics Data to Mechanisms in the Nucleus, Regeneration, and Cancer (Q33726992) (← links)
- The Soft- and Hard-Heartedness of Cardiac Fibroblasts: Mechanotransduction Signaling Pathways in Fibrosis of the Heart (Q33737254) (← links)
- Pregnancy-induced adaptations in intramuscular extracellular matrix of rat pelvic floor muscles (Q33744519) (← links)
- Left ventricular diastolic function in relation to the urinary proteome: a proof-of-concept study in a general population (Q34140378) (← links)
- Disruption of both nesprin 1 and desmin results in nuclear anchorage defects and fibrosis in skeletal muscle (Q34379013) (← links)
- Collagen crosslinking does not dictate stiffness in a transgenic mouse model of skeletal muscle fibrosis (Q34860967) (← links)
- Diastolic Left Ventricular Function in Relation to Urinary and Serum Collagen Biomarkers in a General Population. (Q36222011) (← links)
- Validation of an arterial constitutive model accounting for collagen content and crosslinking (Q36505674) (← links)
- The pathogenesis of cardiac fibrosis. (Q37161329) (← links)
- Increased collagen cross-linking is a signature of dystrophin-deficient muscle. (Q37345809) (← links)
- Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment (Q37519016) (← links)
- Mechanisms underlying the cardiac antifibrotic effects of losartan metabolites. (Q37623540) (← links)
- Progressive right ventricular functional and structural changes in a mouse model of pulmonary arterial hypertension (Q37675518) (← links)
- The myofibroblast matrix: implications for tissue repair and fibrosis. (Q37733670) (← links)
- Myofibroblast-mediated mechanisms of pathological remodelling of the heart (Q38064729) (← links)
- Cell- and molecular-level mechanisms contributing to diastolic dysfunction in HFpEF (Q38441801) (← links)
- Searching for new mechanisms of myocardial fibrosis with diagnostic and/or therapeutic potential (Q38540889) (← links)
- Detrimental role of lysyl oxidase in cardiac remodeling. (Q38698647) (← links)
- Syndecans in heart fibrosis (Q38842278) (← links)
- Skeletal muscle fibroblasts in health and disease (Q38860573) (← links)
- Novel Urinary Peptidomic Classifier Predicts Incident Heart Failure (Q40091740) (← links)
- Cardiac-restricted Overexpression of TRAF3 Interacting Protein 2 (TRAF3IP2) Results in Spontaneous Development of Myocardial Hypertrophy, Fibrosis, and Dysfunction. (Q41049541) (← links)
- Mechanical regulation of cardiac fibroblast profibrotic phenotypes. (Q41229985) (← links)
- MicroRNA-19b is a potential biomarker of increased myocardial collagen cross-linking in patients with aortic stenosis and heart failure (Q42330259) (← links)
- The long noncoding RNA Wisper controls cardiac fibrosis and remodeling (Q42379056) (← links)
- The lysyl oxidase inhibitor (β-aminopropionitrile) reduces leptin profibrotic effects and ameliorates cardiovascular remodeling in diet-induced obesity in rats. (Q46609201) (← links)
- Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix (Q46745968) (← links)
- Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide vs. furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial). (Q47644833) (← links)
- Rationale of the FIBROTARGETS study designed to identify novel biomarkers of myocardial fibrosis (Q47843525) (← links)
- Regional adaptation of collagen in skeletal muscle to repeated bouts of strenuous eccentric exercise (Q48137766) (← links)
- Radiation-induced HFpEF model as a potential tool for the exploration of novel therapeutic targets. (Q48261592) (← links)
- Syndecan-4 is a key determinant of collagen cross-linking and passive myocardial stiffness in the pressure-overloaded heart. (Q52656588) (← links)
- Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trial (Q52803941) (← links)
- Lumican is increased in experimental and clinical heart failure, and its production by cardiac fibroblasts is induced by mechanical and proinflammatory stimuli. (Q53116892) (← links)
- Pathophysiological Mapping of Experimental Heart Failure: Left and Right Ventricular Remodeling in Transverse Aortic Constriction Is Temporally, Kinetically and Structurally Distinct. (Q54968385) (← links)
- Galectin-3 and histological, molecular and biochemical aspects of myocardial fibrosis in heart failure of hypertensive origin (Q57395332) (← links)
- Intermittent Hypoxia Mimicking Sleep Apnea Increases Passive Stiffness of Myocardial Extracellular Matrix. A Multiscale Study (Q58777381) (← links)
- Loss of miR-144 signaling interrupts extracellular matrix remodeling after myocardial infarction leading to worsened cardiac function (Q59340410) (← links)
- Integrative Genomics Analysis Unravels Tissue-Specific Pathways, Networks, and Key Regulators of Blood Pressure Regulation (Q64102103) (← links)
- Low fibrosis biomarker levels predict cardiac resynchronization therapy response (Q64115562) (← links)
- Fibrosis mechanistic phenotyping and antifibrotic response determination with biomarkers in heart failure: one single biomarker may not fit all settings (Q88931662) (← links)
- Does Chronic Kidney Disease Facilitate Malignant Myocardial Fibrosis in Heart Failure with Preserved Ejection Fraction of Hypertensive Origin? (Q89578257) (← links)
- Therapeutic Targets for the Treatment of Cardiac Fibrosis and Cancer: Focusing on TGF-β Signaling (Q90643368) (← links)
- Muscle contracture and passive mechanics in cerebral palsy (Q90667301) (← links)
- Emerging Roles of Lysyl Oxidases in the Cardiovascular System: New Concepts and Therapeutic Challenges (Q90725298) (← links)
- Intrauterine exposure to chronic hypoxia in the rat leads to progressive diastolic function and increased aortic stiffness from early postnatal developmental stages (Q92792152) (← links)